Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Protein Kinases and Phosphatases

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

Protein Kinases and Phosphatases

Protein Kinases and Phosphatases

Assembly of Signaling Complexes

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

Amplifying Signals via Enzymatic Cascade

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Protein-Drug Binding: Mechanism and Kinetics

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Alkyl shikimates promote proliferation of human dermal fibroblasts and exhibit structure-activity relationships.

Scientific reports·2026

Same author

Diterpene Molecular Glue Stabilizes Protein-Protein Interactions of a Disordered Phosphoprotein that Controls Translational Repression.

JACS Au·2026

Same author

Correlation between tight binding of inhibitors and their target selectivity toward the non-native state in the DYRK family of kinases.

Bioorganic & medicinal chemistry letters·2025

Same author

Photoirradiation-Promoted <i>ipso</i>-Azidation of 1-Aryltriazenes.

Organic letters·2025

Same author

Bottom-up design of peptide shapes in water using oligomers of <i>N</i>-methyl-l/d-alanine.

Chemical science·2025

Same author

Osteogenic CpG Oligodeoxynucleotide, iSN40, Inhibits Osteoclastogenesis in a TLR9-Dependent Manner.

Life (Basel, Switzerland)·2025

Search research articles

Related Experiment Video

Updated: Nov 19, 2025

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

Druggable Transient Pockets in Protein Kinases.

Koji Umezawa¹, Isao Kii²

¹Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University, 8304 Minami-Minowa, Kami-ina, Nagano 399-4598, Japan.

Molecules (Basel, Switzerland)

|January 30, 2021

Summary

Researchers discovered FINDY, a novel inhibitor targeting a hidden pocket in DYRK1A kinase during protein folding. This approach offers a new strategy for developing potent kinase inhibitors, overcoming limitations of traditional drug discovery methods.

Keywords:

DYRK1A FINDY chemical screening cryptic binding site folding intermediate protein kinase thermodynamic equilibrium

More Related Videos

Identification of Kinase-substrate Pairs Using High Throughput Screening

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Related Experiment Videos

Last Updated: Nov 19, 2025

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

Identification of Kinase-substrate Pairs Using High Throughput Screening

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Area of Science:

Biochemistry
Drug Discovery
Molecular Biology

Background:

Small molecule inhibitor drug discovery faces challenges like low selectivity and clinical trial failures.
Conventional screening methods may overlook potent inhibitors due to outdated enzyme-based kits.
Non-canonical inhibitors targeting cryptic or transient protein pockets are gaining research interest.

Purpose of the Study:

To introduce the novel inhibitor FINDY, which targets a transient pocket in DYRK1A kinase during its folding process.
To compare FINDY's unique inhibitory mechanism with established kinase inhibitors and the concept of cryptic inhibitor-binding sites.
To explore alternative drug discovery strategies targeting transitional protein folding intermediates.

Main Methods:

Identification and characterization of the inhibitor FINDY targeting DYRK1A.
Comparative analysis of FINDY's inhibitory mechanism against conventional kinase inhibitors.
Discussion of cryptic inhibitor-binding sites and their relevance in drug discovery.
Exploration of cell-free protein synthesis for discovering inhibitors of transient pockets.

Main Results:

FINDY uniquely inhibits DYRK1A by targeting a pocket that is accessible only during the protein's folding process.
The binding pocket for FINDY is hidden in the fully folded DYRK1A protein.
This mechanism differs from traditional inhibitors that target stable, folded protein structures.

Conclusions:

Targeting transient pockets during protein folding, as exemplified by FINDY, represents a promising new avenue for drug discovery.
This approach may overcome limitations associated with traditional small molecule inhibitors.
Cell-free protein synthesis offers a potential method for identifying inhibitors of these cryptic binding sites, leading to more potent kinase inhibitors.